$1.10 EPS Expected for Pinnacle West Capital (PNW), Shorts at Superconductor Tech (SCON) Raised By 23.25%

June 27, 2017 - By Kurt Siggers

Analysts expect Pinnacle West Capital Corporation (NYSE:PNW) to report $1.10 EPS on August, 1.They anticipate $0.02 EPS change or 1.85% from last quarter’s $1.08 EPS. PNW’s profit would be $123.27M giving it 19.94 P/E if the $1.10 EPS is correct. After having $0.21 EPS previously, Pinnacle West Capital Corporation’s analysts see 423.81% EPS growth. About 129,369 shares traded. Pinnacle West Capital Corporation (NYSE:PNW) has risen 18.43% since June 27, 2016 and is uptrending. It has outperformed by 1.73% the S&P500.

Superconductor Tech Incorporated (NASDAQ:SCON) had an increase of 23.25% in short interest. SCON’s SI was 1.21M shares in June as released by FINRA. Its up 23.25% from 980,200 shares previously. With 383,800 avg volume, 3 days are for Superconductor Tech Incorporated (NASDAQ:SCON)’s short sellers to cover SCON’s short positions. The SI to Superconductor Tech Incorporated’s float is 20.44%. About 30,214 shares traded. Superconductor Technologies, Inc. (NASDAQ:SCON) has declined 36.86% since June 27, 2016 and is downtrending. It has underperformed by 53.56% the S&P500.

Pinnacle West Capital Corporation is a holding firm that operates through its subsidiaries. The company has market cap of $9.83 billion. The Firm operates through regulated electricity segment, which consists of traditional regulated retail and wholesale electricity businesses and related activities, and includes electricity generation, transmission and distribution. It has a 21.33 P/E ratio. It owned and leased 6,236 megawatt of regulated generation capacity and the Company held a mix of both long-term and short-term purchased power agreements for additional capacity, including agreements for the purchase of renewable energy, as of December 31, 2016.

Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.07, from 1.04 in 2016Q3. It dived, as 35 investors sold Pinnacle West Capital Corporation shares while 148 reduced holdings. 44 funds opened positions while 133 raised stakes. 88.80 million shares or 0.89% more from 88.02 million shares in 2016Q3 were reported. Keybank Association Oh stated it has 2,846 shares or 0% of all its holdings. California Pub Employees Retirement Systems owns 318,598 shares or 0.04% of their US portfolio. Gemmer Asset Mgmt Limited Liability Com holds 0% or 93 shares in its portfolio. Guardian Life Insur Of America holds 0% or 426 shares in its portfolio. Pacad Investment Limited, a British Columbia – Canada-based fund reported 200 shares. Hussman Strategic Advsrs holds 1,000 shares or 0.02% of its portfolio. Contravisory Invest Mngmt reported 335 shares. Andra Ap holds 45,100 shares or 0.1% of its portfolio. Dekabank Deutsche Girozentrale holds 8,515 shares or 0.01% of its portfolio. American Natl Registered Investment Advisor invested in 0.18% or 5,000 shares. Motco stated it has 0% in Pinnacle West Capital Corporation (NYSE:PNW). Lpl Lc reported 4,728 shares or 0% of all its holdings. Caisse De Depot Et Placement Du Quebec holds 0.03% or 154,456 shares in its portfolio. Ridgeworth Capital Management Ltd Liability invested 0% in Pinnacle West Capital Corporation (NYSE:PNW). Tokio Marine Asset Management Ltd accumulated 3,037 shares.

Among 10 analysts covering Pinnacle West Capital Corporation (NYSE:PNW), 0 have Buy rating, 1 Sell and 9 Hold. Therefore 0 are positive. Pinnacle West Capital Corporation had 27 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Pinnacle West Capital Corporation (NYSE:PNW) has “Neutral” rating given on Tuesday, January 17 by Goldman Sachs. The firm has “Hold” rating by Williams Capital Group given on Tuesday, March 7. UBS maintained Pinnacle West Capital Corporation (NYSE:PNW) rating on Thursday, October 6. UBS has “Neutral” rating and $78 target. RBC Capital Markets maintained Pinnacle West Capital Corporation (NYSE:PNW) on Monday, June 20 with “Sector Perform” rating. The rating was maintained by Mizuho with “Neutral” on Monday, February 27. Mizuho maintained it with “Neutral” rating and $70 target in Monday, February 8 report. Zacks upgraded the shares of PNW in report on Monday, August 17 to “Sell” rating. The stock of Pinnacle West Capital Corporation (NYSE:PNW) has “Underweight” rating given on Tuesday, January 12 by Morgan Stanley. Bank of America upgraded the stock to “Neutral” rating in Tuesday, November 22 report. The rating was maintained by SunTrust with “Neutral” on Monday, September 26.

Since February 19, 2017, it had 0 insider buys, and 14 selling transactions for $14.26 million activity. Shares for $469,328 were sold by MUNRO KATHRYN L. Shares for $4.02M were sold by BRANDT DONALD E. $159,600 worth of Pinnacle West Capital Corporation (NYSE:PNW) shares were sold by GOMEZ BARBARA M. $423,600 worth of stock was sold by GALLAGHER MICHAEL L on Monday, May 15. $249,030 worth of stock was sold by Nickloy Lee R. on Friday, March 3. HATFIELD JAMES R sold $843,499 worth of stock. $156,025 worth of Pinnacle West Capital Corporation (NYSE:PNW) was sold by GULDNER JEFFREY B. on Sunday, February 19.

Among 2 analysts covering Superconductor (NASDAQ:SCON), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Superconductor had 3 analyst reports since September 25, 2015 according to SRatingsIntel. On Wednesday, November 11 the stock rating was upgraded by Ladenburg Thalmann to “Buy”. The stock has “Buy” rating by Rodman & Renshaw on Thursday, April 6. The rating was downgraded by Ladenburg Thalmann on Friday, September 25 to “Neutral”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

  • Ultralife Corp. (ULBI) Reaches $6.70 After 7.00% Down Move, Everpoint Asset Management Has Cut Horizon Pharma Plc (HZNP) Holding
  • Akebia Therapeutics (AKBA) Reaches $14.93 After 3.00% Down Move, MasTec, Inc. (MTZ) Had 8 Analysts Last Week
  • Savara (SVRA) Reaches $6.57 After 6.00% Down Move; Greenwich Wealth Management Has Increased Its Intercontinentalexchange Gro (ICE) Holding
  • Aclaris Therapeutics (ACRS) Reaches $27.05 After 9.00% Up Move; Cubist Systematic Strategies Has Lifted Xcel Energy (XEL) Stake By $316,760
  • MCBC Holdings (MCFT) Reaches $19.49 High on Jun, 28; Maverick Capital LTD Boosted By $618,720 Its Myriad Genetics (MYGN) Stake
  • MCBC Holdings (MCFT) Reaches $19.49 52-Week High; Granahan Investment Management Lowered Its Pacira Pharmaceuticals (PCRX) Position
  • ADMA Biologics (ADMA) Reaches $3.82 After 4.00% Down Move, Last Week Ameriprise Financial, Inc. (AMP) Coverage
  • Nova Measuring Instruments Ltd. (NVMI) Reaches $23.47 After 9.00% Up Move; Steadfast Advisors LP Has Trimmed Apple (AAPL) Holding By $5.89 Million
  • Commerzbank Aktiengesellschaft Has Raised Cerner (CERN) Position By $541,346, Biotime (NYSEMKT:BTX) SI Increased By 4.64%
  • KemPharm (KMPH) Reaches $3.60 After 9.00% Up Move; BIOSOLAR (BSRC) Shorts Up By 828.57%